We previously identified and purified Elongin by its ability to stimulate the rate of elongation by RNA polymerase II in vitro (Bradsher, J. N., Jackson, K. W., Conaway, R. C., and Conaway, J. W. (1993) J. Biol. Chem. 268, 25587-25593). In this report, we present evidence that stimulation of elongation by Elongin requires that the early RNA polymerase II elongation complex undergoes conversion to an Elongin-activable form. We observe (i) that Elongin does not detectably stimulate the rate of promoter-specific transcription initiation by the fully assembled preinitiation complex and (ii) that early RNA polymerase II elongation intermediates first become susceptible to stimulation by Elongin after synthesizing 8 -9-nucleotide-long transcripts. Furthermore, we show that the relative inability of Elongin to stimulate elongation by early elongation intermediates correlates not with the lengths of their associated transcripts but, instead, with the presence of transcription factor IIF (TFIIF) in transcription reactions. By exploiting adenovirus 2 major late promoter derivatives that contain premelted transcriptional start sites and do not require TFIIF, TFIIE, or TFIIH for transcription initiation, we observe (i) that Elongin is capable of strongly stimulating the rate of synthesis of trinucleotide transcripts by a subcomplex of RNA polymerase II, TBP, and TFIIB and (ii) that the ability of Elongin to stimulate synthesis of these short transcripts is substantially reduced by addition of TFIIF to transcription reactions. Here we present these findings, which are consistent with the model that maximal stimulation of elongation by Elongin requires that early elongation intermediates undergo a structural transition that includes loss of TFIIF.
Eukaryotic messenger RNA synthesis is a complex biochemical process catalyzed by multisubunit RNA polymerase II and governed by the action of multiple classes of transcription factors (1) (2) (3) . Elongin is a member of one such class of transcription factors (4, 5) , which all function similarly to activate the overall rate of elongation by RNA polymerase II by suppressing transient pausing by polymerase at many sites along DNA templates. In addition to Elongin, this class includes the eleven-nineteen lysine-rich in leukemia protein (ELL) (6) , ELL2 (7), the Cockayne syndrome complementation group B protein (CSB) (8) , and transcription factor IIF (TFIIF), 1 which is also required for transcription initiation by RNA polymerase II (9) .
Elongin is a three-subunit complex composed of a transcriptionally active A subunit of ϳ770 amino acids and two small ϳ110-amino acid regulatory B and C subunits (10 -12) . Elongins B and C form a stable Elongin BC complex that binds to Elongin A and potently induces its transcriptional activity. Elongin C functions as the inducing ligand and activates transcription through interactions with a conserved sequence motif (consensus sequence (T,S,P)(L,M)XXX(C,S)XXX(V,L,I)) in the Elongin A elongation activation domain (13, 14) . Elongin B appears to perform a chaperone-like function by facilitating binding of Elongin C to Elongin A (10) . Notably, Elongins B and C are also found as integral components of a multiprotein complex containing the product of the von Hippel-Lindau (VHL) tumor suppressor gene (15, 16) . The VHL protein and Elongin A share the conserved Elongin BC binding site motif, and consistent with a role for the Elongin BC complex in tumorigenesis, more than 70% of VHL mutations found in VHL families and sporadic clear cell renal carcinomas result in alteration or deletion of this site (17) .
Our laboratory is investigating the mechanism of action of Elongin. In a previous study exploiting oligo(dC)-tailed DNA templates, we demonstrated that Elongin is capable of stimulating the rate of elongation by RNA polymerase II in the absence of additional transcription factors, suggesting that Elongin acts directly on the ternary elongation complex (5) . In further experiments, we have obtained evidence that, during synthesis of promoter-specific transcripts, maximal stimulation of elongation by Elongin requires prior conversion of the early RNA polymerase II elongation complex to an Elonginactivable form. Here we present these findings, which shed new light on the requirements for interaction of Elongin with the RNA polymerase II elongation complex and suggest that, shortly after initiating transcription from a promoter, the RNA polymerase II transcription complex undergoes a structural transition that renders it maximally sensitive to stimulation by Elongin.
EXPERIMENTAL PROCEDURES
Materials-Unlabeled ultrapure ribonucleoside 5Ј-triphosphates, dATP, and 3Ј-O-MeGTP were purchased from Amersham Pharmacia Biotech. [␣- 32 P]CTP (Ͼ3000 Ci/mmol) was obtained from Amersham Pharmacia Biotech. Dinucleotides CpA and CpU, polyvinyl alcohol (type II), and ␣-amanitin were from Sigma. Acetylated bovine serum albumin and recombinant human placental ribonuclease inhibitors were purchased from Promega. Empty 4-ml spin columns were obtained from 5 Prime 3 3 Prime, Inc., Boulder, CO.
Preparation of DNA Templates-DNA templates containing G-less AdML promoter derivatives Ad(Gϩ13), Ad(Gϩ11), Ad(Gϩ9), Ad(Gϩ7), and Ad(Gϩ5) (Fig. 1) were constructed by oligonucleotide-directed mutagenesis of M13mp19-AdML DNA (18) using the Muta-Gene M13 in vitro mutagenesis kit (Bio-Rad). DNA sequences of G-less AdML promoters were confirmed by dideoxy DNA sequencing using the femtomole DNA Sequencing System (Promega). Ad(Gϩ15) is the AdML promoter derivative in pDN-AdML (19) . To prepare premelted AdML promoter derivatives, single-stranded M13 DNA corresponding to the template strands of AdML promoter derivatives in M13mp19 was prepared as described (20) . Oligonucleotides having the sequence of the non-template strand of each promoter from Ϫ59 to ϩ17 except for a 9-base pair substitution (sequence AAGTAGAAG) from Ϫ9 to Ϫ1 relative to the in vivo AdML transcriptional start site were used as primers to direct synthesis of double-stranded DNA as described (18) . Plasmid or replicative form DNA for each of the G-less AdML promoter derivatives was purified by CsCl density gradient centrifugation and used to prepare duplex DNA templates for transcription. Replicative form or premelted DNAs were digested with KpnI and AvaII to generate ϳ410-base pair fragments. pDN-AdML was digested with EcoRI and NdeI to generate an ϳ310-base pair fragment. DNA fragments were purified by agarose gel electrophoresis and used as templates for transcription. The premelted template used in the experiment shown in Fig. 6 was prepared by annealing an oligonucleotide corresponding to the AdML template strand with sequence 3Ј-CCC CCG ATA TTT TCC CCC ACC CCC  GCG CAA GCA GGA GTG AGA GAA GGA GAT CTC AGC TGG ACG  TCC GTA CGT TCG AAC CG-5Ј to an oligonucleotide with sequence  5Ј-GGG GGC TAT AAA AGG GGG TGG GGG CGC GAA GTA GAA  GAC TCT CTT CCT CTA GAG TCG ACC TGC AGG CAT GCA AGC  TTG GC-3Ј ; underlined bases correspond to the non-complementary DNA between Ϫ9 and Ϫ1 relative to the transcriptional start site.
Preparation of RNA Polymerase II and Initiation Factors-RNA polymerase II and TFIIH were purified from rat liver nuclear extracts as described previously (21) . Recombinant yeast TBP (22, 23) , recombinant TFIIB (24) , and recombinant TFIIF (25) were expressed in Escherichia coli and purified as described. Recombinant TFIIE was prepared as described (26) , except that the 56-kDa subunit was expressed in E. coli strain BL21 (DE3)-pLysS.
Preparation of Elongin Subunits and Elongin
Complexes-Individual recombinant histidine-tagged Elongin A, B, and C subunits were expressed in E. coli, purified from guanidine hydrochloride-solubilized inclusion bodies by Ni 2ϩ -nitrilotriacetic acid-agarose chromatography, and renatured alone or in combination as described previously (10) . The reconstituted Elongin ABC complex was further purified as described (4) by chromatography on consecutive TSK SP 5-PW and TSK phenyl 5-PW HPLC columns. The reconstituted Elongin BC complex was purified as described (27) by TSK DEAE 5-PW HPLC. The Elongin A subunit was purified as described (10) by TSK SP 5-PW HPLC.
Assay of Transcription-Preinitiation complexes were assembled at the AdML promoter at 28°C by a 45-60-min preincubation of 30-l reaction mixtures containing 20 mM Hepes-NaOH (pH 7.9), 20 mM Tris-HCl (pH 7.9), 50 mM KCl, 4 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol, 0.5 mg/ml bovine serum albumin, 2% (w/v) polyvinyl alcohol, 3% (v/v) glycerol, 6 units of recombinant placental ribonuclease inhibitor, ϳ10 ng of DNA template fragment, ϳ5 ng of recombinant yeast TBP, ϳ10 ng of recombinant TFIIB, ϳ10 ng of recombinant TFIIF, ϳ20 ng of recombinant TFIIE, ϳ10 ng of TFIIH, and ϳ0.01 units of RNA polymerase II. Where indicated, ϳ20 ng Elongin ABC or ϳ20 ng Elongin A and ϳ10 ng Elongin BC were included in transcription reactions. Transcription was initiated by addition of 4 l of a solution containing the nucleotides indicated in the figure legends. Reactions were stopped by addition of an equal volume of 9.0 M urea containing 0.025% (w/v) bromphenol and 0.025% (w/v) xylene cyanol FF. Transcripts were analyzed by electrophoresis through polyacrylamide gels containing 25% acrylamide, 3% bisacrylamide, 5.0 M urea, 89 mM Tris base, 89 mM boric acid, and 2 mM EDTA. Transcription was quantitated using a Molecular Dynamics PhosphorImager.
Purification of Paused Elongation Complexes-Transcription reactions were scaled up as needed for each of the experiments shown in Figs. 3-5. Transcription was initiated by addition of nucleotides to the final concentrations indicated in the figure legends. After 10 min at 28°C, 200 -250 l of each reaction mix was applied to a 3 ml of Sephadex G-50 (Sigma catalog number G-50 -150) spin column. Columns were then spun for 5 min at 1100 ϫ g in a swinging bucket rotor to elute elongation complexes. 30 l of eluant were used in each transcription reaction. The spin columns were prepared by packing 3 ml of Sephadex G-50, pre-equilibrated in buffer containing 20 mM HepesNaOH (pH 7.9), 20 mM Tris-HCl (pH 7.9), 50 mM KCl, 4 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol, 0.5 mg/ml bovine serum albumin, and 3% (v/v) glycerol, into a 4-ml empty spin column (5 Prime 3 3 Prime, Inc., Boulder, CO ).
RESULTS

Differential Effects of Elongin on RNA Polymerase II Initiation and Early Elongation
Complexes-To begin to characterize the requirements for interaction of Elongin with the RNA polymerase II elongation complex, we compared the effects of Elongin on transcription initiation and on subsequent elongation of short transcripts initiated by RNA polymerase II at the AdML core promoter in a transcription system reconstituted with purified RNA polymerase II and TFIIH from rat liver and recombinant initiation factors TBP, TFIIB, TFIIE, and TFIIF.
In these experiments, preinitiation complexes were assembled by preincubation of RNA polymerase II and initiation factors with a DNA fragment containing a G-less AdML promoter derivative designated Ad(Gϩ15) (Fig. 1) . The effect of Elongin on transcription initiation was assessed by measuring the ability of Elongin to stimulate the rate of synthesis of abortively initiated, dinucleotide-primed trinucleotide transcripts, in reactions containing [␣-32 P]CTP, ATP, and the initiating dinucleotide CpA, which directs transcription initiation at position Ϫ1 relative to the in vivo AdML transcriptional start site (Fig. 1) . The abortive initiation assay has been widely used to measure synthesis of the first phosphodiester bond of nascent transcripts by both prokaryotic and eukaryotic RNA polymerases (28 -33) . As shown previously, RNA polymerase II will utilize dinucleotides to prime synthesis of AdML promoterspecific transcripts; depending on the dinucleotide primer provided, initiation can occur over an approximately 9-base pair region centered on the normal AdML transcriptional start site (34) . If only a dinucleotide primer and the next nucleotide encoded by the template are provided as substrates for transcription initiation, RNA polymerase II will efficiently synthesize abortively initiated, trinucleotide transcripts.
The effect of Elongin on the rate of elongation by early RNA polymerase II elongation intermediates was assessed by measuring the ability of Elongin to stimulate the rate of accumulation of 15-nucleotide-long transcripts synthesized in the presence of [␣-
32 P]CTP, ATP, UTP, and the chain terminating nucleotide 3Ј-O-MeGTP, which prevents most transcription beyond the first G residue at position ϩ15 in the Ad(Gϩ15) transcript. Because we previously observed that Elongin is capable of stimulating the rate of elongation by RNA polymerase II similarly at both low and near-saturating ribonucleoside triphosphate concentrations (5), these reactions were carried out in the presence of low concentrations of UTP (400 nM) and [␣- To accomplish this, we constructed additional G-less AdML promoter derivatives that direct synthesis of transcripts with their first G residues at 13, 11, 9, 7, and 5 base pairs downstream of the AdML transcriptional start site (Fig. 1) .
In these experiments, preinitiation complexes were assembled by preincubation of RNA polymerase II and initiation factors with DNA fragments containing each of the G-less AdML promoter derivatives. Enriched populations of early RNA polymerase II elongation complexes paused at specific sites downstream of the AdML transcriptional start site were synthesized in the absence of GTP and in the presence of ATP, UTP, [␣- Elongation complexes containing 15-, 13-, and 11-nucleotidelong CpA-initiated transcripts were fully active following purification, since nearly all of these transcripts could be chased into longer RNAs following addition of high concentrations of the four ribonucleoside triphosphates ( Figs. 3 and 4 ; lanes designated 4 NTPs). A fraction of elongation complexes containing 9-nucleotide CpA-or CpU-initiated transcripts and 7-nucleotide CpU-initiated transcripts was inactive after being purified and paused for up to 60 min. We do not know whether the 7-and 9-nucleotide transcripts that fail to chase are contained in arrested elongation complexes or whether they were terminated and released at some point after purification of the complexes. Elongation complexes containing 7-nucleotide-long CpA-initiated transcripts were remarkably labile and became inactive if paused for only brief times (data not shown); these complexes could not, therefore, be used in assays for Elongin activity.
To measure the ability of Elongin to stimulate the rate of incorporation of single nucleotides by early RNA polymerase II elongation complexes, isolated complexes were chased in the presence or absence of Elongin by addition of 3Ј-O-MeGTP to reactions. At high concentrations of 3Ј-O-MeGTP, the reaction was complete within 1 or 2 min. We therefore used low concentrations of 3Ј-O-MeGTP (1.4 -2.8 M) to allow accurate measurement of the rates of nucleotide addition. Each experiment was performed and quantitated 3 to 5 times; representative data are shown in Figs. 3 and 4 . The results can be summarized as follows. Elongin is capable of stimulating the rate of addition of a single 3Ј-O-MeG residue to CpA-initiated transcripts of 15, 13, 11, and 9 nucleotides. Elongin is also able to stimulate the rate of addition of a single 3Ј-O-MeG residue to a CpU-initiated transcript of 9 nucleotides (Fig. 4) . In contrast, the rate of addition of 3Ј-O-MeG to a CpU-initiated transcript of 7 nucle- otides was relatively insensitive to stimulation by Elongin (Fig.  4) . We note that, for elongation complexes containing 9 and 7 nucleotide transcripts, the fraction of active elongation complexes was somewhat variable from experiment to experiment; however, Elongin consistently stimulated the rate of addition of 3Ј-O-MeG to 9-but not 7-nucleotide transcripts. Taken together, these results suggest that the early RNA polymerase II elongation complex undergoes a transition to a form that is more susceptible to stimulation by Elongin once it has synthesized 8 -9-nucleotide transcripts. Finally, we note that more readthrough products are seen in the presence of Elongin in some experiments. We suspect that the increase in readthrough products is because Elongin not only stimulates the rate of addition of 3Ј-O-MeG to transcripts but also stimulates the rate of addition of contaminating GTP in our nucleotide preparations; however, we cannot rule out the possibility that Elongin also stimulates misincorporation.
Synthesis of Abortive Trinucleotide Transcripts Can Be Stimulated by Elongin in the Absence of TFIIF-
In a previous study, we observed that Elongin is capable of stimulating the rate of elongation by RNA polymerase II on oligo(dC)-tailed DNA templates in the absence of additional transcription factors (5), suggesting that Elongin can stimulate elongation through a direct interaction with polymerase, the nascent transcript, the DNA template, or some combination of these components of the ternary elongation complex. As they emerge from the promoter, early RNA polymerase II elongation complexes undergo several dramatic structural changes, which could be prerequisites for functional interaction of Elongin with the ternary complex. These changes include (i) appearance and growth of the nascent transcript, (ii) disassembly of the initiation complex and loss of initiation factors (35, 36) , and perhaps (iii) alterations in the conformation of polymerase itself. In an effort to determine how the early RNA polymerase II elongation complex is converted to an Elongin-activable form, we sought to determine whether susceptibility of early elongation intermediates to stimulation by Elongin correlates with the presence of an extended (Ͼ7 nucleotide) nascent transcript or with the absence of one or more initiation factors.
To investigate these possibilities, we exploited premelted AdML promoter derivatives with non-complementary DNA between positions Ϫ9 and Ϫ1 upstream of the transcriptional start site (Fig. 5A) . Synthesis of short transcripts by RNA polymerase II from these promoters has been shown to depend on TBP and TFIIB but not on TFIIE and TFIIH (18, 37, 38) and is reported to occur at substantially reduced but measurable levels in the absence of TFIIF (39) .
To determine whether TFIIE and TFIIH are responsible for the relative insensitivity of early elongation intermediates to stimulation by Elongin, preinitiation intermediates were assembled at the premelted Ad(Gϩ7) and Ad(Gϩ5) promoters in the presence of RNA polymerase II, TBP, TFIIB, and TFIIF but in the absence of TFIIE and TFIIH. RNA polymerase II elongation complexes that contained CpU-initiated transcripts of 7 or 9 nucleotides were synthesized in the absence of GTP. Following transcription, RNA polymerase II elongation complexes were purified by gel filtration to remove abortively initiated transcripts and unincorporated ribonucleotides. Isolated elongation complexes were chased in the presence or absence of Elongin by addition of 3Ј-O-MeGTP to transcription reactions. Similar to the results obtained in reactions containing TFIIE and TFIIH (Fig. 4) , Elongin is capable of stimulating the rate of addition of a single 3Ј-O-MeG residue to the CpU-initiated 9-nucleotide transcript (Fig. 5B ) but has little effect on the rate of addition of a single 3Ј-O-MeG residue to the CpU-initiated 7-nucleotide transcript (Fig. 5C ). These results suggest that the association of TFIIE and TFIIH with early elongation intermediates cannot account for their relative insensitivity to stimulation by Elongin.
In further experiments investigating the effects of TFIIF and transcript length on the susceptibility of early elongation intermediates to stimulation by Elongin, we observe that Elongin is capable of stimulating synthesis of abortively initiated trinucleotide transcripts by RNA polymerase II at premelted promoters in the presence of only TBP and TFIIB (Fig. 6 ). As shown in Fig. 6 , trinucleotide synthesis at the premelted AdML promoter is inhibited by low concentrations of ␣-amanitin and depends strongly on TBP and TFIIB, arguing (i) that it is catalyzed by RNA polymerase II and (ii) that it is promoterspecific and not carried out by polymerase bound nonspecifically at the single-stranded region of the template. We do observe a low level of background trinucleotide synthesis in reactions that lack TBP or TFIIB. It is well established that RNA polymerase II can initiate transcription on singlestranded DNA (40) . Furthermore, we observe that polymerase synthesizes low levels of abortive trinucleotide transcripts on single-stranded, non-promoter DNA when primed with a dinucleotide in the absence of initiation factors (data not shown). Because the reactions in Fig. 6 were performed with promoters containing single-stranded DNA between Ϫ9 and Ϫ1, this phenomenon is likely to be responsible for the observed levels of background trinucleotide synthesis. Consistent with previous results indicating that both Elongin A and the regulatory Elongin BC complex are needed for maximal stimulation of elongation by RNA polymerase II (4, 10 -12) , maximal stimulation of synthesis of abortive trinucleotide transcripts by Elongin depends on both Elongin A and the Elongin BC complex. Thus, although Elongin does not detectably stimulate the rate of synthesis of abortive trinucleotide transcripts by RNA polymerase II in the complete initiation complex, Elongin is capable of stimulating trinucleotide synthesis when TFIIF is absent. Similarly, we observe that Elongin can stimulate trinucleotide synthesis in the absence of TFIIF when TFIIH and TFIIE are included in reaction mixtures (data not shown). Taken to- gether, these results suggest that an extended nascent transcript is not essential for Elongin function. In addition, they raise the possibility that TFIIF may be responsible for the observed insensitivity of the complete preinitiation complex and of very early elongation complexes to stimulation by Elongin.
To investigate this possibility further, increasing concentrations of TFIIF were added back to abortive initiation reactions carried out in the presence of RNA polymerase II, TBP, and TFIIB (Fig. 7) . Consistent with previous studies (39), TFIIF is capable of strongly stimulating the rate of synthesis of abortive trinucleotide transcripts under these conditions. Furthermore, as the concentration of TFIIF is increased in transcription reactions, the apparent stimulation of trinucleotide synthesis by Elongin decreases dramatically from more than 10-fold in the absence of TFIIF to less than 1.5-fold in the presence of near-saturating TFIIF concentrations (Fig. 7, lower panel) . These results are consistent with the model that TFIIF, but not TBP or TFIIB, is responsible for the relative insensitivity of early elongation intermediates to stimulation by Elongin.
DISCUSSION
Elongin is one of several transcription factors that are capable of increasing the overall rate of elongation by RNA polymerase II. In addition to Elongin, these proteins include ELL (6), ELL2 (7), CSB (8) , and TFIIF (9, (41) (42) (43) , which is also required for initiation by RNA polymerase II from most promoters. All of these proteins are capable of stimulating the rate of elongation by RNA polymerase II on oligo(dC)-tailed DNA templates in the absence of accessory transcription factors, suggesting that they stimulate elongation through a direct interaction with polymerase, the nascent transcript, the DNA template, or some combination of these components of the ternary elongation complex.
In this report, we have investigated the requirements for functional interaction of Elongin with RNA polymerase II that has initiated transcription from a promoter in a basal transcription system reconstituted with the general initiation factors TBP, TFIIB, TFIIE, TFIIF, and TFIIH. The results of these studies indicated (i) that Elongin is unable to stimulate the rate of synthesis of the first phosphodiester bond of nascent transcripts initiated in the presence of all five general initiation factors and (ii) that RNA polymerase II first becomes susceptible to maximal stimulation by Elongin after synthesizing ϳ8 -9-nucleotide transcripts. Taken together, these findings led to the hypothesis that, shortly after initiating transcription, the early RNA polymerase II elongation complex undergoes conversion to an Elongin-activable form.
Efforts to understand the molecular basis of this conversion led us to consider two models. First, it was possible that Elongin could not interact with RNA polymerase II until the enzyme had synthesized ϳ8 -9-nucleotide transcripts, perhaps because Elongin functions at least in part through a direct interaction with the nascent transcript or because Elongin interacts optimally with those polymerases whose conformations have been altered by association with Ͼϳ8 -9-nucleotide transcripts. Second, it was possible that Elongin could, in principle, stimulate the rate of elongation by RNA polymerase II that had synthesized transcripts shorter than ϳ8 -9 nucleotides but that its functional interaction with polymerase was either blocked or masked by association of one or more of the general initiation factors with early elongation intermediates. In particular, in light of evidence that TFIIE, TFIIF, and TFIIH are all capable of interacting with early RNA polymerase II elongation intermediates (18, 36) , functional interaction of Elongin with RNA polymerase II might require prior dissociation of one or more of these general initiation factors from early elongation intermediates.
Our findings are most consistent with the latter model and suggest that dissociation of TFIIF from the early RNA polymerase II elongation complex is required for maximal detectable stimulation of the rate of elongation by Elongin. We observe that Elongin is capable of strongly stimulating the rate of synthesis of transcripts as short as 3 nucleotides from the premelted AdML promoter when TFIIE, TFIIF, and TFIIH are absent from transcription reactions. This observation argues that Elongin action requires neither the presence of an ϳ8 -9-nucleotide nascent transcript nor a specific polymerase conformation dependent on prior synthesis of an ϳ8 -9-nucleotide transcript. In addition, this observation suggests that Elongin activity is unlikely to involve direct interactions with the nascent transcript, since evidence suggests that the 5Ј-end of growing transcripts does not emerge from RNA polymerase II until they are longer than ϳ8 -9 nucleotides (44 -46) . In this regard, Elongin differs from several bacterial elongation factors, such as rho factor and nusG, which control the activity of bacterial RNA polymerase at least in part through direct interactions with the nascent transcript (47, 48) .
Elongin activity is also not directly affected by TFIIE and TFIIH, since these factors do not affect the ability of Elongin to stimulate the rate of synthesis of abortive trinucleotide transcripts from the premelted AdML promoter in the absence of TFIIF 2 and, furthermore, since they do not change the point at which early elongation complexes first become susceptible to stimulation by Elongin when TFIIF is present. In contrast, inclusion of TFIIF in abortive transcription reactions on the premelted AdML template results in both a substantial increase in the rate of synthesis of abortive trinucleotide transcripts and a substantial decrease in the fold stimulation of abortive transcription by Elongin. Based on these results, we propose that TFIIF is in large part responsible for the apparent inability of Elongin to stimulate synthesis of the first phosphodiester bond of transcripts initiated in the presence of all five general initiation factors and that conversion of the RNA polymerase II elongation complex to a form that is susceptible to maximal stimulation by Elongin requires dissociation of TFIIF from early elongation intermediates.
The results presented in this paper do not allow us to determine how interaction of TFIIF with early RNA polymerase II elongation intermediates might render them relatively refractory to stimulation by Elongin. Evidence from previous studies suggests that TFIIF remains stably associated with early RNA polymerase II elongation intermediates until they have synthesized transcripts of ϳ10 nucleotides (36) . In contrast to its tight association with early transcription intermediates, however, TFIIF does not bind stably to RNA polymerase II elongation complexes that have synthesized longer transcripts (9) . Thus, one possibility is that TFIIF binds to early RNA polymerase II elongation intermediates and sterically prevents Elongin from interacting with them. According to this model, Elongin would gain access to RNA polymerase II only after TFIIF had dissociated from early elongation intermediates. Notably, such a mechanism controls the interaction of E. coli elongation factor nusA with E. coli RNA polymerase. The binding of NusA and the initiation factor 70 to E. coli RNA polymerase is mutually exclusive (49); thus, NusA is able to interact with polymerase only after dissociation of 70 from early elongation complexes. An alternative possibility is that Elongin can physically interact with RNA polymerase II elongation complexes prior to synthesis of ϳ8 -9-nucleotide transcripts but does not alter the rate of transcript synthesis because polymerase activity is already maximally stimulated by the elongation activity of TFIIF. TFIIF concentrations required for detectable stimulation of elongation are typically much greater than those used in our assays to saturate promoter-specific initiation (42), presumably because TFIIF does not bind stably to ternary elongation complexes. Because TFIIF is stably associated with very early elongation complexes, it is possible that it can stimulate elongation by these transcription intermediates and thereby mask Elongin activity, even when present at the low concentration used in our assays.
Finally, our findings provide insight into the mechanism by which Elongin stimulates elongation by RNA polymerase II. Substantial evidence argues that both prokaryotic and eukaryotic RNA polymerases can cycle between active and inactive conformations at each step of nucleotide addition during synthesis of a transcript (50 -56) . For each step of nucleotide addition, the average rate of nucleotide addition (the step time) often appears to be limited, not by the rate of phosphodiester bond formation (k cat ) but by the fraction of time polymerase spends in the inactive conformation. Sites of extended transcriptional pausing, then, would correspond to sites where polymerase has a high probability of falling into an inactive state or where, once inactivated, it does not readily cycle back into the active conformation.
An estimate of the maximum length of time needed for phosphodiester bond formation by RNA polymerase II is provided by measurements indicating that step times at saturating nucleotide concentrations vary from milliseconds to seconds (57) (58) (59) . Thus, our observation that Elongin is capable of significantly decreasing the step time of RNA polymerase II, even when ribonucleoside triphosphate concentrations are extremely low and when a single nucleotide addition reaction requires 30 min to reach completion, suggests that Elongin does not stimulate elongation simply by decreasing k cat . Moreover, it is not likely that Elongin has a major effect on the K M values for ribonucleoside triphosphates, since we observed previously that Elongin is capable of stimulating the rate of elongation by RNA polymerase II to a similar extent when reactions contain either low or near saturating concentrations of ribonucleoside triphosphates (5) . Instead, as proposed previously for TFIIF (9, 55) , it seems more likely that Elongin increases the rate of nucleotide addition by RNA polymerase II by increasing the fraction of polymerase molecules in an active conformation at any given time. Notably, evidence from previous studies suggests that Elongin is capable of decreasing the frequency and/or duration of transient pausing by polymerase at many sites along the DNA template (5, 60) . Elongin could accomplish this either by interacting specifically with polymerase in the inactive conformation and converting it to an active form or by interacting specifically with active polymerase and locking it into the active conformation until the incoming ribonucleoside triphosphate binds properly in the active site and a phosphodiester bond is formed.
Although the nature of the structural transition(s) underlying conversion of RNA polymerases from active to inactive conformations is presently unknown, studies of transcriptionally arrested polymerases have led to the proposal that at least some inactive polymerase conformations result from misalignment of the 3Ј-OH of the nascent transcript with catalytic site residues required for binding the incoming ribonucleoside triphosphate and catalyzing formation of the next phosphodiester bond (45, 55, 56, (61) (62) (63) (64) . We previously observed that Elongin has the capacity to promote template-directed extension by RNA polymerase II of the 3Ј-OH termini of DNA molecules (65) . As suggested by Salzman and co-workers (66), the template-directed addition of ribonucleotides to 3Ј-OH termini of DNA by RNA polymerase II may occur in a reaction that mimics formation of the ternary elongation complex. In this case, the RNA polymerase II catalytic site for nucleotide addition would use the DNA 3Ј-OH as if it were the 3Ј-end of the nascent RNA transcript. In light of this model, Elongin may promote extension of DNA molecules by RNA polymerase II by facilitating proper positioning of DNA 3Ј-OH termini with respect to the polymerase catalytic site and, by extension, might help to maintain polymerase in an active conformation by a similar mechanism.
